May 25, 2022
Bristol Myers Squibb Chairman and CEO Giovanni Caforio The biggest challenge of the pharmaceutical industry is to carry on its drive to accelerate drug development post COVID-19 by leveraging its experiences with vaccines and therapeutics developed during the pandemic, Bristol...read more